Fund Holdings — CAXTON CORP

Total Portfolio Value:
$24.16M
Total Bought:
$1.04M
Total Sold:
$210.2K
Net Transaction:
+$834.1K
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Xeris Biopharma Holdings Inc5,113,3485,113,3480$11.51M$14.57M60.31%+$3.07M
Rezolute, Inc.(RZLT)1,318,9671,318,9670$5.67M$6.40M26.47%+$725.4K
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)1,8692,867+998$1.02M$1.64M6.81%+$628.0K
Berkshire Hathaway Inc DelCL B1,0251,151+126$417.1K$529.6K2.19%+$112.5K
Bicara Therapeutics Inc010,941+10,941$0$278.7K1.15%+$278.7K
Mind Medicine Mindmed Inc30,38334,073+3,690$219.1K$193.9K0.80%-$25.2K
Lexeo Therapeutics, Inc.(LXEO)17,85117,8510$286.3K$161.4K0.67%-$125.0K
ABIVAX Société AnonymeADS(ABVX)13,90011,365-2,535$183.8K$130.9K0.54%-$52.8K
Kyverna Therapeutics, Inc.(KYTX)22,98122,9810$172.4K$112.4K0.47%-$60.0K
Compass Therapeutics, Inc.(CMPX)43,46543,4650$43.5K$80.0K0.33%+$36.5K
Context Therapeutics Inc.(CNTX)18,40318,4030$36.9K$36.1K0.15%-$828
Adicet Bio Inc17,48817,4880$21.2K$25.2K0.10%+$4.0K
Molecular Templates Inc136,8660-136,866$157.4K$0—-$157.4K
Page 1 of 1
CAXTON CORP — 13F Holdings — Q3 2024 | TickerTrail